News

National HPV Awareness Day on the 27th January 2017

CERVIVA is delighted to announce that it will host a National HPV Awareness Day on the 27th January 2017. The symposium is targeted at healthcare professionals interested or working in the area. It aims to review the burden of HPV associated cancers in men and women globally and recent developments in this field.

The importance of preparatory sensory information for follow-up procedures in cervical cancer screening

new paper published by researchers from CERVIVA sheds light on women’s sensory experiences of colposcopy and related procedures. The findings of the research suggest women require more preparatory sensory information.

CERVIVA researcher wins best oral presentation award at the BSCCP 2016 meeting

Dr Prerna Tewari, CERVIVA HRB ICE Fellow, was recently awarded best oral presentation at the British Society for Colposcopy & Cervical Pathology (BSCCP) 2016 meeting. The winning presentation was on the role of triage markers (e.g. HPV mRNA, p16/Ki67) in the management of HPV positive w

The addition of p16/Ki-67 to HPV testing leads to more accurate stratification of minor cervical abnormalities

CERVIVA researchers have recently published significant findings on the triage of minor abnormal cervical cytology, LSIL and ASCUS. In recent years there has been widespread implementation of HPV testing as part of cervical screening and triage of minor cervical abnormalities.

Comparator Strategies in Cost-Effectiveness Analyses of HPV Testing in Cervical Screening

CERVIVA investigators have recently published a review of economic analyses of new HPV-based tests in cervical cancer screening. Screening for cervical cancer with HPV tests is generally found to be more effective than conventional screening that uses cytology tests (smear tests) alone.

CERVIVA investigators present their research findings at HPV 2015 in Portugal

The 30th International Papillomavirus Conference (HPV 2015) takes place in Lisbon, Portugal from September 17-21. The conference focuses on HPV (human papillomavirus) which is a known cause of cervical cancer and is also implemented in other diseases (e.g. head and neck cancers).

Pages

Subscribe to News